Global RNAi Technologies, Markets & Companies Report 2020-2028: Gene Editing with for COVID-19 by RNA-Targeting CRISPR Systems & mRNA Vaccines for COVID-19
20 avr. 2021 06h23 HE
|
Research and Markets
Dublin, April 20, 2021 (GLOBE NEWSWIRE) -- The "RNAi - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. The markets for RNAi...
Respiratory Assist Devices Market Value Predicted To Reach US$ 30.3 Billion By 2027: Acumen Research And Consulting
08 avr. 2021 11h52 HE
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Respiratory Assist Devices Market– Global Industry Analysis, Market Size,...
Global Antisense & RNAi Therapeutics Market (2020 to 2030) - Opportunities and Strategies
07 avr. 2021 05h23 HE
|
Research and Markets
Dublin, April 07, 2021 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change" report has been added to...
Global Antisense and RNAi Therapeutics Market Report 2021: Market to Reach $1.9 Billion by 2027 - Antisense RNA Segment is Projected to Account for $974.2 Million
30 mars 2021 07h38 HE
|
Research and Markets
Dublin, March 30, 2021 (GLOBE NEWSWIRE) -- The "Antisense and RNAi Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
Global Viral Vector & Plasmid DNA Manufacturing Market Report 2021 - Rising Use of Viral Vectors in Several Treatments Demands Developments in Plasmids and Vectors
17 févr. 2021 05h48 HE
|
Research and Markets
Dublin, Feb. 17, 2021 (GLOBE NEWSWIRE) -- The "Viral Vector & Plasmid DNA Manufacturing Market Research Report by Type, by Workflow, by Application, by End User - Global Forecast to 2025 -...
OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate
10 févr. 2021 17h45 HE
|
OliX Pharmaceuticals
Company to discuss study results and present corporate overview at SMi’s 12th Annual RNA Therapeutics Virtual Conference on February 11 SUWON, Republic of Korea, Feb. 10, 2021 (GLOBE NEWSWIRE) --...
Global RNA Interference Drug Delivery Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast
21 déc. 2020 06h53 HE
|
Research and Markets
Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "RNA Interference (RNAi) Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
NapaJen Pharma Reports Positive Results from Phase 1 Clinical Trial of Novel RNA Interference (RNAi) Therapeutic
08 oct. 2020 07h35 HE
|
NapaJen
NJA-730 is an Anti-CD-40 Oligonucleotide Combined with Beta-Glucan Delivery Vehicle with Potential to Treat Acute Graft-versus-Host Disease (aGvHD) Treatment Shown to be Safe and Well-Tolerated...
Global RNAi Technologies, Markets & Companies Report 2020 with Profiles of 167 Companies Along with 229 Collaborations
21 sept. 2020 04h13 HE
|
Research and Markets
Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The "RNAi - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. The report...
World RNAi Market 2020-2025: Oncology is Expected to Hold Significant Market Share in the Therapeutics Type Area
31 août 2020 05h44 HE
|
Research and Markets
Dublin, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The "RNA-interference (RNAi) Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The...